Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Change in Accured Expenses (2022 - 2025)

Historic Change in Accured Expenses for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$96000.0.

  • Envoy Medical's Change in Accured Expenses fell 10736.76% to -$96000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 23871.36%. This contributed to the annual value of $891000.0 for FY2024, which is 104787.23% up from last year.
  • Envoy Medical's Change in Accured Expenses amounted to -$96000.0 in Q3 2025, which was down 10736.76% from $113000.0 recorded in Q2 2025.
  • Over the past 5 years, Envoy Medical's Change in Accured Expenses peaked at $1.3 million during Q3 2024, and registered a low of -$982000.0 during Q2 2024.
  • Moreover, its 4-year median value for Change in Accured Expenses was $113000.0 (2025), whereas its average is $76400.0.
  • Examining YoY changes over the last 5 years, Envoy Medical's Change in Accured Expenses showed a top increase of 36140.4% in 2023 and a maximum decrease of 43248.95% in 2023.
  • Over the past 4 years, Envoy Medical's Change in Accured Expenses (Quarter) stood at $237000.0 in 2022, then tumbled by 432.49% to -$788000.0 in 2023, then soared by 217.64% to $927000.0 in 2024, then plummeted by 110.36% to -$96000.0 in 2025.
  • Its last three reported values are -$96000.0 in Q3 2025, $113000.0 for Q2 2025, and $199000.0 during Q1 2025.